
Microtechnix is a product-oriented company specializing in the digitization and automation of Pharmaceutical Microbiology Quality Control (QC) using imaging technology. Founded in 2013 by Wouter Christiaens, the company develops innovative hardware and software solutions, notably the EMMA system launched in 2024. Their offerings include advanced image-acquisition devices and Vision AI tools designed to automate and streamline QC processes, reduce hands-on time, and ensure compliance with data integrity standards like ALCOA+ and 21 CFR Part 11. Microtechnix serves biotech, pharmaceutical, CDMO, and medical device manufacturers globally, emphasizing a scalable, end-to-end approach from R&D to aftercare. They are certified with ISO 9001:2015 and adhere to GAMP and CMSE guidelines, demonstrating a commitment to quality, reliability, and regulatory compliance.

Microtechnix is a product-oriented company specializing in the digitization and automation of Pharmaceutical Microbiology Quality Control (QC) using imaging technology. Founded in 2013 by Wouter Christiaens, the company develops innovative hardware and software solutions, notably the EMMA system launched in 2024. Their offerings include advanced image-acquisition devices and Vision AI tools designed to automate and streamline QC processes, reduce hands-on time, and ensure compliance with data integrity standards like ALCOA+ and 21 CFR Part 11. Microtechnix serves biotech, pharmaceutical, CDMO, and medical device manufacturers globally, emphasizing a scalable, end-to-end approach from R&D to aftercare. They are certified with ISO 9001:2015 and adhere to GAMP and CMSE guidelines, demonstrating a commitment to quality, reliability, and regulatory compliance.